$EVR2025 · v5

Evercore (EVR): 13.3x EV/EBITDA and 9.1x EV/FCF Price a Durable Upcycle Question

Interesting research candidate

68Signal score
2025Fiscal year
Financial ServicesSector
68Interesting research candidate
Report date
Monday, 15 June 2026
Company
Evercore Inc.
Sector
Financial Services
Industry
Financial - Capital Markets
Version
v5

Research summary

Interesting research candidate

What could invalidate the thesis

  • !

    Deal volume is cyclical — a prolonged rate environment or recession could suppress advisory fee revenue.

  • !

    Key-person dependency: departure of senior partners would weaken long-standing client relationships.

  • !

    Fee compression from larger bulge-bracket and regional firms competing on the same mandates.

Questions an investor should verify

Before acting on any research, verify these claims at the primary source, not from the article or report.

  • Review the latest 10-K for EVR revenue breakdown by business segment.

  • Check the proxy statement for partner or key-person retention disclosures.

  • Compare EV/EBITDA and ROE against direct peers on recent earnings calls.

  • Verify guidance commentary in the most recent earnings transcript.

How SignalShield reviewed this report

SignalShield reviewed available financial media, earnings commentary, and sector coverage for Evercore Inc. to produce this signal score. The score reflects sourcing quality, framing objectivity, certainty of language, and the presence of counterarguments in available coverage. Not a recommendation to buy or sell.

Read the methodology →Signal score definitions →

Research PDF

signalshield-EVR-2025-v5.pdf
Download PDF
⬇ Download full PDFDirect download. Opens in any PDF reader. Public archive report.

Check the article behind your thesis

SignalShield reviews the articles, threads, and newsletters you read about EVR for unsupported claims, promotional framing, and missing counterarguments, before you act on them.

Add to Chrome, freeSee SignalShield Pro

Manual scans only. No brokerage access. No investment advice.

This report is provided for informational research support only. It does not constitute investment, financial, or trading advice.

← All research reports